Ovid Therapeutics Inc.
OVID
$0.3383
-$0.0117-3.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 53.08M | 62.71M | 76.97M | 90.26M | 105.83M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.87M | 3.12M | 3.92M | 2.91M | 3.76M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 1.00K |
| Total Current Assets | 55.94M | 65.83M | 80.89M | 93.17M | 109.60M |
|
|
|||||
| Total Current Assets | 55.94M | 65.83M | 80.89M | 93.17M | 109.60M |
| Net Property, Plant & Equipment | 13.23M | 13.59M | 13.98M | 14.31M | 14.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 92.00K | 155.00K | 219.00K | -- | 200.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.93M | 1.96M | 1.96M | 2.11M | 1.94M |
| Total Assets | 92.17M | 102.65M | 118.09M | 131.61M | 144.03M |
|
|
|||||
| Total Accounts Payable | 3.19M | 2.71M | 4.72M | 3.60M | 3.70M |
| Total Accrued Expenses | 5.99M | 7.61M | 8.11M | 4.04M | 6.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.34M | 1.31M | 1.29M | 1.27M | 1.25M |
| Total Finance Division Other Current Liabilities | 1.00K | -- | -- | -- | -- |
| Total Other Current Liabilities | 1.00K | -- | -- | -- | -- |
| Total Current Liabilities | 10.52M | 11.63M | 14.12M | 8.90M | 11.47M |
|
|
|||||
| Total Current Liabilities | 10.52M | 11.63M | 14.12M | 8.90M | 11.47M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.42M | 13.76M | 14.10M | 14.43M | 14.76M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 972.00K | 972.00K | 30.00M | 30.00M |
| Total Liabilities | 23.94M | 26.36M | 29.19M | 53.33M | 56.23M |
|
|
|||||
| Common Stock & APIC | 372.56M | 371.30M | 369.95M | 367.86M | 365.66M |
| Retained Earnings | -304.30M | -295.05M | -281.04M | -289.56M | -277.87M |
| Treasury Stock & Other | -35.00K | 36.00K | -12.00K | -19.00K | 0.00 |
| Total Common Equity | 68.23M | 76.29M | 88.90M | 78.28M | 87.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00 |
|
|
|||||
| Total Common Equity | 68.23M | 76.29M | 88.90M | 78.28M | 87.80M |
| Total Preferred Equity | -- | -- | -- | -- | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 68.23M | 76.29M | 88.90M | 78.28M | 87.80M |
|
|
|||||